Auto-generated: May 21 2012 04:50 AM GMT-8

533
Stars
Star This?

Source: DGNews  |  Posted 9 years ago

ELOXATIN, Chemotherapy for Advanced Colorectal Cancer, Receives Approval from the U.S. Food and Drug Administration

ELOXATIN Provides a New Treatment for Patients with Advanced Colorectal Cancer

PARIS, FRANCE -- August 12, 2002 -- Sanofi-Synthelabo (Euronext: "SAN" / NYSE: SNY) today announced that ELOXATIN

533
Stars
Star This?  Yes / No
 
Sign InSign In
inst val